Shorter radiation with chemo for glioblastoma patients under 70
Part of Cancer clinical trials.
This trial tests a shorter course of radiation therapy combined with the chemotherapy drug temozolomide for people with glioblastoma, a type of brain cancer. The goal is to see if this approach is effective and safe for patients under 70 who are otherwise in good health.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must have a confirmed diagnosis of glioblastoma.
- You must be between 18 and 70 years old.
- You must be in good overall health, able to care for yourself (Karnofsky score above 70%).
- You must not have had radiation therapy to the head before.
- You must be able to have MRI scans (no metal implants or pacemakers that prevent MRI).
- You must be willing to use contraception if you are of childbearing age, and not be pregnant.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether a more focused, stronger dose of radiation can improve outcomes for people 65 and older with newly diagnosed glioblastoma. It compares this approach to standard radiation to see if it's safe and effective.
This trial is testing a new way to deliver radiation therapy to a smaller area of the brain after surgery for glioblastoma. The goal is to see if this more focused approach can treat the tumor effectively while possibly reducing side effects and protecting healthy brain tissue.
This trial is testing whether a drug called G-CSF (which helps boost white blood cells) can help people with glioblastoma who are already receiving standard treatment with radiation and chemotherapy (temozolomide). It aims to see if G-CSF can reduce side effects and improve outcomes.
This trial tests a shorter, more intense course of radiation therapy (hypofractionated radiotherapy) for people with newly diagnosed glioblastoma who have had surgery. The goal is to see if this approach is safe and works well for treating the tumor.
This trial tests a new, shorter course of radiation therapy (called hypofractionation) for people with glioblastoma that has come back. It is for patients who have already had radiation and are doing well enough to consider another round.
This trial tests a shorter course of radiation (hypofractionated RT) for people with a specific type of aggressive brain tumor (GBM) that is not suitable for surgery. It aims to see if this shorter treatment can be effective with fewer side effects.
Hear when a new Glioblastoma (GBM) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.